Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Alfred

Showing results (311-320 of 434) with videos related to

Pageof 44
Sort By:
Investigative Radiology|February 2, 2012
Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score ≤ 3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated seriesDiederik M Somford, Thomas Hambrock, Christina A Hulsbergen-van de Kaa, et al.
BJU International|April 17, 2025
The impact of treatment for muscle-invasive bladder cancer on health-related quality of lifeSiberyn T Nuijens, Lisa M C van Hoogstraten, Noëlle B Terpstra, et al.
The Prostate|May 27, 2008
Detailed analysis of histopathological parameters in radical prostatectomy specimens and PCA3 urine test resultsMartijn P M Q van Gils, Daphne Hessels, Christina A Hulsbergen-van de Kaa, et al.
Radiology|September 18, 2004
Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imagingWillem M L L G Deserno, Mukesh G Harisinghani, Matthias Taupitz, et al.
World Journal of Urology|May 31, 2023
Low adherence to recommended use of neoadjuvant chemotherapy for muscle-invasive bladder cancerLisa M C van Hoogstraten, Calvin C O Man, J Alfred Witjes, et al.
European Urology|December 1, 2006
Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical featuresGeert J L H van Leenders, Danny Dukers, Daphne Hessels, et al.
European Urology|February 2, 2010
Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendationsJ Alfred Witjes, Juan Palou Redorta, Didier Jacqmin, et al.
Urologic Oncology|May 11, 2010
Discrepancy between clinical staging through bimanual palpation and pathological staging after cystectomyMartine Ploeg, Lambertus A L M Kiemeney, Geert A Smits, et al.
European Journal of Cancer (Oxford, England : 1990)|June 2, 2006
Segregation analysis of urothelial cell carcinomaKatja K H Aben, Laura Baglietto, Agnes Baffoe-Bonnie, et al.
Genome Announcements|January 7, 2017
Complete Genome Sequences of 38 Gordonia sp. BacteriophagesWelkin H Pope, Matthew T Montgomery, J Alfred Bonilla, et al.
Pageof 44

Showing results (311-320 of 434) with videos related to

Sort By:
Pageof 44
Investigative Radiology|February 2, 2012
Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score ≤ 3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated seriesDiederik M Somford, Thomas Hambrock, Christina A Hulsbergen-van de Kaa, et al.
BJU International|April 17, 2025
The impact of treatment for muscle-invasive bladder cancer on health-related quality of lifeSiberyn T Nuijens, Lisa M C van Hoogstraten, Noëlle B Terpstra, et al.
The Prostate|May 27, 2008
Detailed analysis of histopathological parameters in radical prostatectomy specimens and PCA3 urine test resultsMartijn P M Q van Gils, Daphne Hessels, Christina A Hulsbergen-van de Kaa, et al.
Radiology|September 18, 2004
Urinary bladder cancer: preoperative nodal staging with ferumoxtran-10-enhanced MR imagingWillem M L L G Deserno, Mukesh G Harisinghani, Matthias Taupitz, et al.
World Journal of Urology|May 31, 2023
Low adherence to recommended use of neoadjuvant chemotherapy for muscle-invasive bladder cancerLisa M C van Hoogstraten, Calvin C O Man, J Alfred Witjes, et al.
European Urology|December 1, 2006
Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical featuresGeert J L H van Leenders, Danny Dukers, Daphne Hessels, et al.
European Urology|February 2, 2010
Hexaminolevulinate-guided fluorescence cystoscopy in the diagnosis and follow-up of patients with non-muscle-invasive bladder cancer: review of the evidence and recommendationsJ Alfred Witjes, Juan Palou Redorta, Didier Jacqmin, et al.
Urologic Oncology|May 11, 2010
Discrepancy between clinical staging through bimanual palpation and pathological staging after cystectomyMartine Ploeg, Lambertus A L M Kiemeney, Geert A Smits, et al.
European Journal of Cancer (Oxford, England : 1990)|June 2, 2006
Segregation analysis of urothelial cell carcinomaKatja K H Aben, Laura Baglietto, Agnes Baffoe-Bonnie, et al.
Genome Announcements|January 7, 2017
Complete Genome Sequences of 38 Gordonia sp. BacteriophagesWelkin H Pope, Matthew T Montgomery, J Alfred Bonilla, et al.
Pageof 44